{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:27:07Z","timestamp":1794479227893,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cgh.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T01:55:49Z","timestamp":1715651749000},"page":"2211-2220.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4296-7901","authenticated-orcid":false,"given":"Loren","family":"Laine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Spechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Yadlapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Schnoll-Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neila","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Leifke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Fass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.05.004_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib2","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"5","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2024.05.004_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.05.004_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/apt.16295","article-title":"Review article: potassium-competitive acid blockers for the treatment of acid-related disorders","volume":"53","author":"Abdel-Aziz","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib5","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/internalmedicine.0492-17","article-title":"Efficacy of vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant non-erosive reflux disease","volume":"57","author":"Nikura","year":"2018","journal-title":"Intern Med"},{"issue":"1\u20137","key":"10.1016\/j.cgh.2024.05.004_bib6","article-title":"Evaluation of the efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a phase III, randomized, double-blind, placebo-controlled, multicenter study","volume":"81\u201382","author":"Kinoshita","year":"2016","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.cgh.2024.05.004_bib7","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000101","article-title":"Efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a randomized, placebo-controlled, phase 3 study","volume":"10","author":"Kinoshita","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.2002.05769.x","article-title":"Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial","volume":"97","author":"Miner","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2036.2003.01771.x","article-title":"Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis","volume":"18","author":"Katz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib10","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s10620-005-3000-3","article-title":"Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease","volume":"50","author":"Kahrilas","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.05.004_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2009.04013.x","article-title":"Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease","volume":"29","author":"Fass","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.curtheres.2005.08.012","article-title":"Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease: once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term","volume":"66","author":"Janssen","year":"2005","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.cgh.2024.05.004_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2004.02155.x","article-title":"Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND study","volume":"20","author":"Tsai","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/00365529708996509","article-title":"Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice","volume":"32","author":"Venables","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib15","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.3748\/wjg.v19.i45.8408","article-title":"Proton pump inhibitor for non-erosive reflux disease: a meta-analysis","volume":"19","author":"Zhang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib16","article-title":"The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2024.05.004_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"10","author":"Bate","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2036.2010.04508.x","article-title":"Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease","volume":"33","author":"Kinoshita","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1524-4733.2007.00313.x","article-title":"Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease","volume":"11","author":"Junghard","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.cgh.2024.05.004_bib20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2008.175810","article-title":"Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease","volume":"58","author":"Savarino","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.05.004_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1572-0241.2006.00525.x","article-title":"Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid","volume":"101","author":"Shapiro","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.05.004_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2036.2008.03666.x","article-title":"Functional heartburn vs non-erosive reflux disease: similarities and differences","volume":"27","author":"Hershcovici","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.05.004_bib23","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s10620-013-2728-4","article-title":"The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease","volume":"58","author":"Park","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.05.004_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2982.2012.01888.x","article-title":"PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis","volume":"24","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.05.004_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response","volume":"32","author":"Lind","year":"1997","journal-title":"Scand J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524004439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524004439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T08:12:53Z","timestamp":1729671173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524004439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1542356524004439"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.05.004","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}